循环瘤细胞:从新的生物学见解到临床实践
Xuyu Gu1, Shiyou Wei2, Xin Lv3
1Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Signal transduction and targeted therapy
|September 1, 2024
概括
循环瘤细胞 (CTC) 中的DNA甲基化变化对于癌症转移至关重要. 了解CTC中的这些表观遗传修饰可以导致早期检测和向治疗的新生物标志物.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 癌症转移,瘤细胞的扩散,是死亡的主要原因.
- 循环瘤细胞 (CTC) 是转移的关键媒介.
- 基因甲基化是调节基因表达和细胞过程的关键表观遗传机制.
研究的目的:
- 审查DNA甲基化在CTCs形成和传播中的作用.
- 分析DNA甲基化变化在转移期间对CTCs的影响.
- 探索DNA甲基化在癌症患者中CTCs的临床影响.
主要方法:
- 关于癌症转移中的DNA甲基化综合文献综述.
- 对CTCs与表皮细胞-介质细胞过渡 (EMT),免疫监测和殖民有关的表观遗传修饰的分析.
- 探索CTC DNA甲基化生物标记物的临床应用.
主要成果:
- 在致癌和CTC形成过程中,DNA甲基化模式 (低甲基化和高甲基化) 被改变.
- 在CTC的表观遗传修饰影响关键的转移过程,如EMT,免疫逃避,和殖民.
- 在CTC中改变的DNA甲基化具有作为癌症检测,预后和治疗的生物标志物的潜力.
结论:
- DNA甲基化是CTC传播和癌症转移的一个重要因素.
- 了解CTC DNA甲基化提供了对转移机制的见解.
- 针对CTC中的表观遗传修饰可能会改善癌症患者的治疗结果和治疗策略.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


